This clinical research study is evaluating an investigational drug in people with fibromyalgia. “Investigational” means that the drug is still being tested and isn’t approved for use by the general public.
Investigational drug dose 1
Investigational drug dose 2
If you take part in this clinical research study, you’ll be assigned to 1 of 3 study groups. Two of these groups will receive the investigational drug, while the third will receive placebo. Placebo looks like the investigational drug, but it contains no active drug.
You will receive study drug (the investigational drug or placebo) at no cost.
The study drug will be a capsule that you’ll take by mouth. Your study doctor will tell you how often to take it.
Study tests include physical examinations, ECGs (electrocardiograms), and blood and urine samples.
You will participate for up to 18 weeks and have 7 visits at the study clinic.
You will receive compensation for your time and travel.
You may leave the study at any time.
But the first step is finding out if you may qualify. Please take the study questionnaire to see if this clinical research study may be an option for you.